With the use of two genetically labeled lines of Djungarian hamster cells and the method of hybrid selection on a HAT-selective medium it was found that in the irradiated mixed culture of the above cell lines, cells were formed that survived in the conditions of total destruction of irradiated parent cells. The chromosome analysis showed that about 45% of the survived cells were hybrids resulting from the radiation-induced fusion of two initial cell lines. These hybrid cells were capable of reproduction. A subline of hybrid cells was isolated. It is assumed that the radiation-induced process of cell fusion and the formation of viable somatic hybrids might be essential for the survival of cell population in the course of tumor radiotherapy.
Download full-text PDF |
Source |
---|
Pharmaceuticals (Basel)
December 2024
Computational Biology Laboratory, Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu 603203, Tamil Nadu, India.
Inflammation serves as a vital response to diverse harmful stimuli like infections, toxins, or tissue injuries, aiding in the elimination of pathogens and tissue repair. However, persistent inflammation can lead to chronic diseases. Peptide therapeutics have gained attention for their specificity in targeting cells, yet their development remains costly and time-consuming.
View Article and Find Full Text PDFMolecules
December 2024
Departamento de Química Orgánica I, Facultad de Farmacia and Centro de Investigación Lascaray (Lascaray Research Center), Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
The synthesis of phosphorous indenoquinolines and their biological evaluation as topoisomerase 1 (TOP1) inhibitors and antiproliferative agents were performed. First, the preparation of new hybrid 5-indeno[2,1-]quinolines with a phosphine oxide group was performed by a two-step Povarov-type [4+2]-cycloaddition reaction between the corresponding phosphorated aldimines with indene in the presence of BF·EtO. Subsequent oxidation of the methylene present in the structure resulted in the corresponding indeno[2,1-]quinolin-7-one phosphine oxides .
View Article and Find Full Text PDFMaterials (Basel)
December 2024
National Institute of Materials Physics, Atomistilor Street, No 405 A, 077125 Magurele, Romania.
Nanocomposites based on FeO and carbonaceous nanoparticles (CNPs), including carbon nanotubes (CNTs) and graphene derivatives (graphene oxide (GO) and reduced graphene oxide (RGO)), such as FeO@GO, FeO@RGO, and FeO@CNT, have demonstrated considerable potential in a number of health applications, including tissue regeneration and innovative cancer treatments such as hyperthermia (HT). This is due to their ability to transport drugs and generate localized heat under the influence of an alternating magnetic field on FeO. Despite the promising potential of CNTs and graphene derivatives as drug delivery systems, their use in biological applications is hindered by challenges related to dispersion in physiological media and particle agglomeration.
View Article and Find Full Text PDFMaterials (Basel)
December 2024
Faculty of Mechanical Engineering, Military University of Technology, Gen. Kaliskiego Str., 00-908 Warsaw, Poland.
Based on a combination of hexagonal honeycomb and re-entrant honeycomb cells, the concept of novel hybrid cell structures was developed. Experimental studies and numerical analyses of the behaviour of the analysed structures under in-plane compression in two compression directions were carried out. Explicit finite element analyses with an explicit integration scheme, incorporating plastic deformation and ductile damage evolution models, were employed to analyse the entire deformation process, including plastic and damage stages.
View Article and Find Full Text PDFLife (Basel)
December 2024
División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Hemophilia B is a genetic disorder characterized by clotting factor IX deficiency and bleeding in joints and muscles. Current treatments involve intravenous infusion of plasma-derived products or recombinant proteins, which have limited efficacy due to the short half-life of infused proteins. Recently, gene therapy for bleeding disorders has offered a potential solution.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!